EP Patent

EP3506906A4 — TOPICAL FENOLDOPAM FORMULATIONS FOR THE TREATMENT OF SKIN DISEASES

Assigned to Taro Pharmaceutical Industries Ltd · Expires 2020-08-12 · 6y expired

What this patent protects

Patent listed against Alphagan.

Drugs covered by this patent

Alphagan (BRIMONIDINE TARTRATE) · Senju Pharmaceutical Co., Ltd

Patent Metadata

Patent number: EP3506906A4
Jurisdiction: EP
Classification: —
Expires: 2020-08-12
Drug substance claim: No
Drug product claim: No
Assignee: Taro Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.